脑部放疗，上午比下午敏感许多！
) v" S5 {5 L+ V8 i: s7 l' c, f: B2 m- J9 u
7 O1 h5 @/ S( z% F
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. V+ B% O H6 T2 w5 x
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?8 A. h% w! P4 ] _- T
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
1 d0 ~. |2 g y& i5 y2 pSourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.9 s. t& N$ y) m1 Q- g/ _2 @
6 Z! x4 Z* M, A$ Q7 G/ `
Abstract- x1 ?( H! A7 }
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.: p O9 C7 N6 h8 S. N9 \; U8 L, A: a
6 I7 m; ]' \1 }6 D; e* F+ K+ BMETHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
! I" K- M# I5 @) `3 _3 g7 n2 h' V5 ?
3 P; U. A$ t) }; ~- DRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).
" v7 m9 J* S& N9 D8 {2 ^0 ]& ~4 i4 P7 ]8 D2 e8 {9 p: ]3 G W
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.. `: M8 F: X' v
" V/ |4 R; f' s* h* `2 _& E |
显身卡
